S860-119

Reported

BUST FENTANYL Act

119th Congress Introduced Mar 5, 2025

Summary

What This Bill Does

The BUST FENTANYL Act uses reporting, diplomacy, and sanctions to target fentanyl precursor supply chains. It changes the International Narcotics Control Strategy Report timing and precursor-chemical language; requires State and DOJ to report within 180 days on U.S. efforts to secure PRC controls over unregulated fentanyl precursors such as 4-AP, PRC financial-system and money-laundering roles, the Trilateral Fentanyl Committee, the Global Coalition to Address Synthetic Drug Threats, third-country commitments, supply-chain shifts, and relevant roles of India, Mexico, and other countries; requires a classified briefing on efforts to establish DEA offices in Shanghai and Guangzhou; prioritizes identification of PRC persons shipping fentanyl, analogues, precursors, pre-precursors, and equipment to Mexico or other production countries; expands Fentanyl Sanctions Act coverage to significant opioid-trafficking activity, proceeds, support, ownership, control, or acting on behalf of covered persons; authorizes sanctions on foreign state agencies, instrumentalities, government-owned financial institutions, and senior officials; and expands annual methamphetamine source-country reporting.

Who Benefits and How

U.S. communities harmed by fentanyl benefit if sanctions and diplomacy disrupt precursor shipments, money laundering, and trafficking networks. DEA investigators benefit from required reporting and classified briefings on efforts to establish offices in Shanghai and Guangzhou. Congressional judiciary and foreign affairs committees benefit from detailed reports on PRC, Mexican, Indian, and third-country precursor activity. Treasury sanctions offices benefit from expanded statutory categories for opioid-trafficking sanctions. Canada, Mexico, and Global Coalition partners benefit from U.S. pressure for coordinated synthetic-drug enforcement.

Who Bears the Burden and How

PRC chemical suppliers and equipment providers face prioritized identification if they ship fentanyl inputs to Mexico or other production countries. PRC financial institutions and money-laundering organizations face scrutiny and potential designation for narcotics-related laundering. Foreign state agencies, instrumentalities, government-owned financial institutions, and senior officials face sanctions if they materially contribute to opioid trafficking. The Secretary of State, Attorney General, President, and sanctions agencies must produce reports, briefings, certifications, and designations. Foreign governments identified as methamphetamine source countries face annual reporting on precursor controls and trafficking actions.

Key Provisions

  • Requires State and DOJ reports on PRC fentanyl precursor controls, PRC money laundering, multilateral efforts, third-country commitments, and supply-chain shifts.
  • Directs classified briefings on DEA access and efforts to establish DEA offices in Shanghai and Guangzhou.
  • Prioritizes identification of PRC persons involved in shipping fentanyl, analogues, precursors, pre-precursors, and manufacturing equipment.
  • Expands Fentanyl Sanctions Act coverage to opioid-trafficking activity, proceeds, support, ownership, control, and acting-on-behalf relationships.
  • Authorizes sanctions on foreign state agencies, instrumentalities, government-owned financial institutions, and senior officials involved in opioid trafficking.
  • Requires annual reporting on methamphetamine source countries and their precursor-control actions.

Evidence Chain:

This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.

At a Glance

What This Bill Does

Expands U.S. fentanyl and methamphetamine reporting and sanctions by focusing on PRC precursor supply chains, DEA access in China, PRC financial institutions and money laundering organizations, foreign state agencies and senior officials that facilitate opioid trafficking, and source-country reporting for methamphetamine.

Key Policy Areas

Drug Policy, Sanctions, Foreign Affairs

Primary Purpose

Expands U.S. fentanyl and methamphetamine reporting and sanctions by focusing on PRC precursor supply chains, DEA access in China, PRC financial institutions and money laundering organizations, foreign state agencies and senior officials that facilitate opioid trafficking, and source-country reporting for methamphetamine.

Policy Domains

Drug Policy Sanctions Foreign Affairs

Bill provisions

Identified Gains
  • U.S. communities harmed by fentanyl
  • DEA investigators
  • Congressional judiciary committees
  • Treasury sanctions offices
  • Synthetic-drug coalition partners
Model: codex-gpt-5 | Version: bill_summary_v2 | Source: is
DEA investigators: , , , , ,
Treasury sanctions offices: , , , , ,
Synthetic-drug coalition partners: , , , , ,
Congressional judiciary committees: , , , , ,
U.S. communities harmed by fentanyl: , , , , ,
Identified Costs
  • PRC chemical suppliers
  • PRC financial institutions
  • Foreign state agencies involved in opioid trafficking
  • Secretary of State
  • Attorney General
  • President
Model: codex-gpt-5 | Version: bill_summary_v2 | Source: is
President: , , , , ,
Attorney General: , , , , ,
Secretary of State: , , , , ,
PRC chemical suppliers: , , , , ,
PRC financial institutions: , , , , ,
Foreign state agencies involved in opioid trafficking: , , , , ,

Legislative Progress

Reported
Introduced Committee Passed
Apr 28, 2025

Reported by Mr. Risch, without amendment

Apr 28, 2025

Placed on Senate Legislative Calendar under General Orders. Calendar No. …

Apr 28, 2025

Committee on Foreign Relations. Reported by Senator Risch without amendment. …

Mar 27, 2025

Committee on Foreign Relations. Ordered to be reported without amendment …

Mar 5, 2025

Introduced in Senate

Mar 5, 2025

Mr. Risch (for himself and Mrs. Shaheen) introduced the following …

Mar 5, 2025

Read twice and referred to the Committee on Foreign Relations.

Mar 5, 2025

Mr. Risch (for himself, Mrs. Shaheen, Mr. Hagerty, and Mr. …

Stakeholder Effects

cui bono?

How this legislation distributes effects. Mention counts reflect frequency, not effect magnitude.

Government
54 mentions across 9 clauses
+27 positive -27 negative

Attorney General, Congressional judiciary committees, Foreign state agencies involved in opioid trafficking

Positive-direction: Congressional judiciary committees, Synthetic-drug coalition partners, Treasury sanctions offices

Negative-direction: Attorney General, Foreign state agencies involved in opioid trafficking, Secretary of State

General Public
9 mentions across 9 clauses
+9 positive

U.S. communities harmed by fentanyl

Law Enforcement
9 mentions across 9 clauses
+9 positive

DEA investigators

Manufacturing
9 mentions across 9 clauses
-9 negative

PRC chemical suppliers

Financial Services
9 mentions across 9 clauses
-9 negative

PRC financial institutions

3/7
sections analyzed
Full impact breakdown

Bill Structure & Actor Mappings

Who is "The Secretary" in each section?

Domains
Drug Policy Sanctions Foreign Affairs
Actor Mappings
"secretary"
→ Secretary of State
"attorney_general"
→ Attorney General

We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.

Learn more about our methodology